Initial public offering of Calliditas Therapeutics AB (SE) on Nasdaq Stockholm — SEK 747 million

Carnegie acted as sole global co-ordinator and sole bookrunner in the initial public offering of Calliditas on Nasdaq Stockholm. Calliditas is a specialty pharmaceutical company based in Stockholm, Sweden, focused on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications in which Calliditas can partially or completely participate in the commercialization efforts. June 2018.